Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection FractionChan Soon Park, Dong‐Ju Choi, Jin Joo Park et al.|Journal of the American Heart Association|2019Cited by 113
Bortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosisJi-Yun Lee, Kihyun Kım, Sung Hee Lim et al.|Amyloid|2014Cited by 23
Generalised autonomic failure as a prognostic factor in systemic light-chain (AL) amyloidosisSoonwook Kwon, Byoung Joon Kim, Ju‐Hong Min et al.|Amyloid|2022Cited by 9
Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in KoreaSeok Jin Kim, Kihyun Kım, Ga Yeon Lee et al.|Amyloid|2013Cited by 5
A comprehensive overview of AL amyloidosis disease characteristics accumulated over two decades at a single referral center in KoreaSang Eun Yoon, Kihyun Kım, Darae Kim et al.|International Journal of Hematology|2022Cited by 4